Profile
Donald Handley worked as a Director of Global Regulatory Affairs at Bausch & Lomb, Inc. and as a Director of Regulatory Affairs at Cleveland BioLabs, Inc. Prior to that, he was a Manager of Worldwide Regulatory Affairs at Bristol Myers Squibb Co. and a Senior Manager of Regulatory Affairs at Celltech Medeva.
He received his undergraduate and graduate degrees from The State University of New York and also holds an MBA.
Former positions of Donald Handley
| Companies | Position | End |
|---|---|---|
| Celltech Medeva /Anesthetic Business/ | General Counsel | 2001-12-31 |
| BRISTOL-MYERS SQUIBB COMPANY | General Counsel | 1998-12-31 |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | General Counsel | - |
| STATERA BIOPHARMA, INC. | General Counsel | - |
Training of Donald Handley
| The State University of New York | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private companies | 3 |
|---|---|
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Health Technology |
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
| Celltech Medeva /Anesthetic Business/ | Health Technology |
- Stock Market
- Insiders
- Donald Handley
